Evidence map›Paper›PMID 36213646›Full record

ArticleFrontiers in medicine2022

Successful therapeutic strategy for a patient with obese end-stage kidney disease by simultaneous laparoscopic sleeve gastrectomy and implantation of a buried peritoneal dialysis catheter: A case report.

Tomohisa Yamashita, Tatsuya Sato, Kazuyuki Yamamoto, Atsuko Abiko, Keitaro Nishizawa, Masahiro Matsuda, Yuma Ebihara, Takeshi Maehana, Toshiaki Tanaka, Toshiyuki Yano and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Tomohisa YamashitaDepartment of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
Tatsuya SatoDepartment of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
Kazuyuki YamamotoDepartment of Surgery, Japanese Red Cross Asahikawa Hospital, Asahikawa, Japan.
Atsuko AbikoDepartment of Diabetic and Endocrinologic Medicine, Japanese Red Cross Asahikawa Hospital, Asahikawa, Japan.
Keitaro NishizawaDepartment of Nephrology, Japanese Red Cross Asahikawa Hospital, Asahikawa, Japan.
Masahiro MatsudaDepartment of Nephrology, Japanese Red Cross Asahikawa Hospital, Asahikawa, Japan.
Yuma EbiharaDepartment of Gastroenterological Surgery II, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Takeshi MaehanaDepartment of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Toshiaki TanakaDepartment of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Toshiyuki YanoDepartment of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
Hironori KobayashiDepartment of Nephrology, Japanese Red Cross Asahikawa Hospital, Asahikawa, Japan.
Japanese Red Cross Asahikawa Hospital · JPSapporo Medical University · JPHokkaido University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For morbidly obese patients with end-stage kidney disease (ESKD), there are often difficulties in accessing, implementing, and maintaining kidney replacement therapy (KRT). Although recent weight-loss surgery has the potential to solve these problems, its therapeutic strategy and appropriate perioperative management for morbidly obese patients with ESKD have not been established. Here, we describe the case history of a 47-year-old man diagnosed with ESKD due to obesity-related glomerulopathy with an uncorrected estimated glomerular filtration rate (eGFR) of 16.1 ml/min. He hoped for kidney transplantation but was not eligible due to his high body mass index (BMI) (36.9 kg/m

Indexed as

a buried catheter for peritoneal dialysisend-stage kidney diseasekidney transplantationlaparoscopic sleeve gastrectomyobesitypersonalized therapeutic approach

Identifiers

PMID36213646
PMCPMC9537543
OpenAlexW4297004052

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.